Reversal of liver cirrhosis: current evidence and expectations
Young Kul Jung, Hyung Joon Yim
Korean J Intern Med. 2017;32(2):213-228.   Published online 2017 Feb 8     DOI:
Citations to this article as recorded by Crossref logo
Lipophagy and liver disease: New perspectives to better understanding and therapy
Zili Zhang, Zhen Yao, Yifan Chen, Lei Qian, Shuoyi Jiang, Jingyi Zhou, Jiangjuan Shao, Anping Chen, Feng Zhang, Shizhong Zheng
Biomedicine & Pharmacotherapy.2018; 97: 339.     CrossRef
Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B
D.-P. Liu, W. Lu, Z.-Q. Zhang, Y.-B. Wang, R.-R. Ding, X.-L. Zhou, D. Huang, X.-F. Li
Journal of Viral Hepatitis.2018; 25(5): 581.     CrossRef
Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14
Eszter Regős, Hadeer Hesham Abdelfattah, Andrea Reszegi, László Szilák, Klára Werling, Gábor Szabó, András Kiss, Zsuzsa Schaff, Ilona Kovalszky, Kornélia Baghy
Matrix Biology.2018; 68-69: 474.     CrossRef
Dysregulation of fibrosis related genes in HCV induced liver disease
Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady
Gene.2018; 664: 58.     CrossRef
Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
Devaraj Ezhilarasan, Etienne Sokal, Mustapha Najimi
Hepatobiliary & Pancreatic Diseases International.2018; 17(3): 192.     CrossRef
Fagonia indica Repairs Hepatic Damage through Expression Regulation of Toll-Like Receptors in a Liver Injury Model
Fareeha Azam, Nadeem Sheikh, Gibran Ali, Asima Tayyeb
Journal of Immunology Research.2018; 2018: 1.     CrossRef
The role of chemerin and vaspin in Egyptian patients with viral hepatitis C
Shawkey Ali, Doha Ellakwa, Sally Emara, Noha El-Sabbagh
Meta Gene.2018; 18: 23.     CrossRef
Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B
D. Liu, J. Li, W. Lu, Y. Wang, X. Zhou, D. Huang, X. Li, R. Ding, Z. Zhang
Clinical Microbiology and Infection.2018;[Epub]     CrossRef
New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article
Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour
Middle East Journal of Digestive Diseases.2018; 10(3): 133.     CrossRef
Transcriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular Carcinoma
Marwa Zahra, Hassan Azzazy, Ahmed Moustafa
Scientific Reports.2018;[Epub]     CrossRef
Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C
Ali Afsari, Edward Lee, Babak Shokrani, Tina Boortalary, Zaki A. Sherif, Mehdi Nouraie, Adeyinka O. Laiyemo, Kawtar Alkhalloufi, Hassan Brim, Hassan Ashktorab
Digestive Diseases and Sciences.2017; 62(8): 2159.     CrossRef
Metabolomic profiling for identification of metabolites and relevant pathways for taurine in hepatic stellate cells
Xin Deng, Xing-Qiu Liang, Fei-Guo Lu, Xiao-Fang Zhao, Lei Fu, Jian Liang
World Journal of Gastroenterology.2017; 23(31): 5713.     CrossRef
Cellular senescence and liver disease: Mechanisms and therapeutic strategies
Mei Guo
Biomedicine & Pharmacotherapy.2017; 96: 1527.     CrossRef